Global Crohn’s Disease Treatment Market Projected to Surpass USD 21.06 Billion by 2032

As per Zion Market Research, the global Crohn’s disease market is expected to reach USD 21.06 billion by 2032, growing at a CAGR of 4.2% during the forecasted period 2024–2032. Crohn’s disease is a chronic inflammatory bowel disease that affects the gastrointestinal tract and is typically detected in two different age groups (15–35 years of age and 60–80 years). The drug developments are done in the market for the treatment of Crohn’s disease that has been proven beneficial. In addition, altering lifestyles and surge in smoking has resulted in more people being affected by Crohn’s disease, thus stoking further development in the market.

Some of the key players in the market are Allergan, Inc.; AbbVie Inc.; Bristol-Myers Squibb; Bayer AG; F. Hoffmann-La Roche; Boehringer Ingelheim GmbH; GlaxoSmithKline plc; Eli Lilly and Co.; Johnson & Johnson; Janssen Biotech, Inc.; Pfizer Inc.; Novartis International AG; Takeda Pharmaceutical Company Limited; and Sanofi.

Increasing Demand For Better Diagnostics & Treatment Options To Boost The Global Crohn’s Disease Market

The evident trends in the global Crohn’s disease market are intensifying preference for symptomatic drugs & therapeutic than surgeries and drug development in the market owing to substantial money being invested into research & development activities by manufacturers. The increasing drug treatments for Crohn’s disease & augmenting demand for improved analysis and treatment alternatives for the autoimmune disease are some of the major factors that are driving the growth of the market. Additionally, the surge in the number of patients suffering from auto-immune disorders across emerging countries and augmenting administration initiatives for enhancing health care infrastructure is fueling the expansion of the global Crohn’s disease market. Nevertheless, less awareness amongst people concerning the disease is also limiting the development of the market. On the other hand, patent expiry of different useful drugs—like Humira and Remicade—is hindering the growth of the market.

The global Crohn’s disease market is bifurcated on the basis of procedures, drug types, and regional analysis. Based on the procedures, the market is divided into colonoscopy, flexible sigmoidoscopy, MRI (magnetic resonance imaging), CT (computerized tomography), capsule endoscopy, small bowel imaging & double-balloon endoscopy, and others. Based on the drug types, the market is divided into antibiotics, anti-diarrheal, anti-inflammatory drugs pain relievers, immune system suppressors, and others.

The North America Region Expected To Dominate The Global Crohn’s Disease Market Over Estimated Period

Based on geographical analysis, the global Crohn’s disease market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The North American region dominates the global market and has a major share in the market and is expected to maintain its position during the forecasted period. The region is accredited to the noteworthy incidence of Crohn’s disease across the region, primarily Canada and the U.S. The European region follows the North America region in relation to share of the global Crohn’s disease market.

Browse the full “Crohn’s Disease Treatment Market - By Procedures (Colonoscopy, Flexible Sigmoidoscopy, Magnetic Resonance Imaging, Computerized Tomography, Capsule Endoscopy, Small Bowel Imaging & Double-Balloon Endoscopy, And Others), By Drug Types (Antibiotics, Anti-Diarrheal, Anti-Inflammatory Drugs Pain Relievers, Immune System Suppressors, And Others), And By Region - Global Industry Perspective, Comprehensive Analysis, And Forecast, 2019 – 2025.” Report at https://www.zionmarketresearch.com/report/crohns-disease-market

The global Crohn’s disease market is segmented as follows:

By procedures:

• Magnetic Resonance Imaging (MRI)
• Flexible Sigmoidoscopy
• Colonoscopy
• Capsule Endoscopy
• Computerized Tomography (CT)
• Small Bowel Imaging & Double-Balloon Endoscopy
• Others

By drug types:

• Immune System Suppressors
• Anti-Diarrheal
• Antibiotics
• Anti-Inflammatory Drugs Pain Relievers
• Others

By region:

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com